chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood fibrinogen decreased, Brain death, Cerebral haematoma, Computerised tomogram head abnormal, Decompressive craniectomy
Clinical narrative: CEREBRAL VENOUS SINUS THROMBOSIS; SEVERE HEADACHE; DIZZINESS; VOMITING; This spontaneous report received from a consumer's sister via (1198162-1) concerned a 45-year-old female. The patient's weight, height, and medical history were not reported.  The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered once on 13-MAR-2021 as prophylactic vaccination. No concomitant medications were reported.  On 20-MAR-2021, (one-week post-vaccination), the patient experienced severe headache, dizziness, and vomiting. The patient visited an emergency room (ER) as the symptoms continued.  On an unspecified date, in the ER, the patient experienced cerebral venous sinus thrombosis. She was pronounced brain death, and the same day she was pronounced dead. It was unspecified if an autopsy was performed.  The action taken with COVID-19 vaccine ad26.cov2.s was not applicable. The patient died of cerebral venous sinus thrombosis, and had not recovered from dizziness, vomiting, and severe headache. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0: This case concerns a 45-year-old female patient who experienced a fatal cerebral venous sinus thrombosis (CVST) 7 days after receiving covid-19 vaccine ad26.cov2.s for prevention of symptomatic SARS-CoV-2 virus infection. The patient experienced severe headache, dizziness, and vomiting 7 days after vaccination which prompted a visit to the emergency department where she was diagnosed with the cerebral venous sinus thrombosis. On an unspecified date she was pronounced brain dead and subsequently died the same day. It was unspecified if an autopsy was performed. Information is limited in this case, but the CVST could represent background incidence of such event in general population, however a relationship with Janssen Covid-19 vaccine cannot be ruled out.  Therefore, the relationship is indeterminant. Additional information has been requested.; Reported Cause(s) of Death: CEREBRAL VENOUS SINUS THROMBOSIS
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Headache, Influenza A virus test negative, Influenza B virus test, Influenza virus test negative
Clinical narrative: CEREBRAL VENOUS SINUS THROMBOSIS; SEVERE HEADACHE; DIZZINESS; VOMITING; This spontaneous report received from a consumer's sister via (1198162-1) concerned a 45-year-old female. The patient's weight, height, and medical history were not reported.  The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered once on 13-MAR-2021 as prophylactic vaccination. No concomitant medications were reported.  On 20-MAR-2021, (one-week post-vaccination), the patient experienced severe headache, dizziness, and vomiting. The patient visited an emergency room (ER) as the symptoms continued.  On an unspecified date, in the ER, the patient experienced cerebral venous sinus thrombosis. She was pronounced brain death, and the same day she was pronounced dead. It was unspecified if an autopsy was performed.  The action taken with COVID-19 vaccine ad26.cov2.s was not applicable. The patient died of cerebral venous sinus thrombosis, and had not recovered from dizziness, vomiting, and severe headache. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0: This case concerns a 45-year-old female patient who experienced a fatal cerebral venous sinus thrombosis (CVST) 7 days after receiving covid-19 vaccine ad26.cov2.s for prevention of symptomatic SARS-CoV-2 virus infection. The patient experienced severe headache, dizziness, and vomiting 7 days after vaccination which prompted a visit to the emergency department where she was diagnosed with the cerebral venous sinus thrombosis. On an unspecified date she was pronounced brain dead and subsequently died the same day. It was unspecified if an autopsy was performed. Information is limited in this case, but the CVST could represent background incidence of such event in general population, however a relationship with Janssen Covid-19 vaccine cannot be ruled out.  Therefore, the relationship is indeterminant. Additional information has been requested.; Reported Cause(s) of Death: CEREBRAL VENOUS SINUS THROMBOSIS
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Intracranial pressure increased, Mucosal hypertrophy, Nausea, Platelet count decreased, Pupillary reflex impaired
Clinical narrative: CEREBRAL VENOUS SINUS THROMBOSIS; SEVERE HEADACHE; DIZZINESS; VOMITING; This spontaneous report received from a consumer's sister via (1198162-1) concerned a 45-year-old female. The patient's weight, height, and medical history were not reported.  The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered once on 13-MAR-2021 as prophylactic vaccination. No concomitant medications were reported.  On 20-MAR-2021, (one-week post-vaccination), the patient experienced severe headache, dizziness, and vomiting. The patient visited an emergency room (ER) as the symptoms continued.  On an unspecified date, in the ER, the patient experienced cerebral venous sinus thrombosis. She was pronounced brain death, and the same day she was pronounced dead. It was unspecified if an autopsy was performed.  The action taken with COVID-19 vaccine ad26.cov2.s was not applicable. The patient died of cerebral venous sinus thrombosis, and had not recovered from dizziness, vomiting, and severe headache. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0: This case concerns a 45-year-old female patient who experienced a fatal cerebral venous sinus thrombosis (CVST) 7 days after receiving covid-19 vaccine ad26.cov2.s for prevention of symptomatic SARS-CoV-2 virus infection. The patient experienced severe headache, dizziness, and vomiting 7 days after vaccination which prompted a visit to the emergency department where she was diagnosed with the cerebral venous sinus thrombosis. On an unspecified date she was pronounced brain dead and subsequently died the same day. It was unspecified if an autopsy was performed. Information is limited in this case, but the CVST could represent background incidence of such event in general population, however a relationship with Janssen Covid-19 vaccine cannot be ruled out.  Therefore, the relationship is indeterminant. Additional information has been requested.; Reported Cause(s) of Death: CEREBRAL VENOUS SINUS THROMBOSIS
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Respiratory syncytial virus test negative, SARS-CoV-2 test negative, White blood cell count increased
Clinical narrative: CEREBRAL VENOUS SINUS THROMBOSIS; SEVERE HEADACHE; DIZZINESS; VOMITING; This spontaneous report received from a consumer's sister via (1198162-1) concerned a 45-year-old female. The patient's weight, height, and medical history were not reported.  The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered once on 13-MAR-2021 as prophylactic vaccination. No concomitant medications were reported.  On 20-MAR-2021, (one-week post-vaccination), the patient experienced severe headache, dizziness, and vomiting. The patient visited an emergency room (ER) as the symptoms continued.  On an unspecified date, in the ER, the patient experienced cerebral venous sinus thrombosis. She was pronounced brain death, and the same day she was pronounced dead. It was unspecified if an autopsy was performed.  The action taken with COVID-19 vaccine ad26.cov2.s was not applicable. The patient died of cerebral venous sinus thrombosis, and had not recovered from dizziness, vomiting, and severe headache. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0: This case concerns a 45-year-old female patient who experienced a fatal cerebral venous sinus thrombosis (CVST) 7 days after receiving covid-19 vaccine ad26.cov2.s for prevention of symptomatic SARS-CoV-2 virus infection. The patient experienced severe headache, dizziness, and vomiting 7 days after vaccination which prompted a visit to the emergency department where she was diagnosed with the cerebral venous sinus thrombosis. On an unspecified date she was pronounced brain dead and subsequently died the same day. It was unspecified if an autopsy was performed. Information is limited in this case, but the CVST could represent background incidence of such event in general population, however a relationship with Janssen Covid-19 vaccine cannot be ruled out.  Therefore, the relationship is indeterminant. Additional information has been requested.; Reported Cause(s) of Death: CEREBRAL VENOUS SINUS THROMBOSIS
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood fibrinogen, Brain death, CSF pressure, Cerebral haematoma, Computerised tomogram
Clinical narrative: CEREBRAL VENOUS SINUS THROMBOSIS; SEVERE HEADACHE; DIZZINESS; VOMITING; This spontaneous report received from a consumer's sister via (1198162-1) concerned a 45-year-old female. The patient's weight, height, and medical history were not reported.  The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered once on 13-MAR-2021 as prophylactic vaccination. No concomitant medications were reported.  On 20-MAR-2021, (one-week post-vaccination), the patient experienced severe headache, dizziness, and vomiting. The patient visited an emergency room (ER) as the symptoms continued.  On an unspecified date, in the ER, the patient experienced cerebral venous sinus thrombosis. She was pronounced brain death, and the same day she was pronounced dead. It was unspecified if an autopsy was performed.  The action taken with COVID-19 vaccine ad26.cov2.s was not applicable. The patient died of cerebral venous sinus thrombosis, and had not recovered from dizziness, vomiting, and severe headache. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0: This case concerns a 45-year-old female patient who experienced a fatal cerebral venous sinus thrombosis (CVST) 7 days after receiving covid-19 vaccine ad26.cov2.s for prevention of symptomatic SARS-CoV-2 virus infection. The patient experienced severe headache, dizziness, and vomiting 7 days after vaccination which prompted a visit to the emergency department where she was diagnosed with the cerebral venous sinus thrombosis. On an unspecified date she was pronounced brain dead and subsequently died the same day. It was unspecified if an autopsy was performed. Information is limited in this case, but the CVST could represent background incidence of such event in general population, however a relationship with Janssen Covid-19 vaccine cannot be ruled out.  Therefore, the relationship is indeterminant. Additional information has been requested.; Reported Cause(s) of Death: CEREBRAL VENOUS SINUS THROMBOSIS
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head, Headache, Influenza, Intracranial pressure increased, Platelet disorder
Clinical narrative: CEREBRAL VENOUS SINUS THROMBOSIS; SEVERE HEADACHE; DIZZINESS; VOMITING; This spontaneous report received from a consumer's sister via (1198162-1) concerned a 45-year-old female. The patient's weight, height, and medical history were not reported.  The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered once on 13-MAR-2021 as prophylactic vaccination. No concomitant medications were reported.  On 20-MAR-2021, (one-week post-vaccination), the patient experienced severe headache, dizziness, and vomiting. The patient visited an emergency room (ER) as the symptoms continued.  On an unspecified date, in the ER, the patient experienced cerebral venous sinus thrombosis. She was pronounced brain death, and the same day she was pronounced dead. It was unspecified if an autopsy was performed.  The action taken with COVID-19 vaccine ad26.cov2.s was not applicable. The patient died of cerebral venous sinus thrombosis, and had not recovered from dizziness, vomiting, and severe headache. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0: This case concerns a 45-year-old female patient who experienced a fatal cerebral venous sinus thrombosis (CVST) 7 days after receiving covid-19 vaccine ad26.cov2.s for prevention of symptomatic SARS-CoV-2 virus infection. The patient experienced severe headache, dizziness, and vomiting 7 days after vaccination which prompted a visit to the emergency department where she was diagnosed with the cerebral venous sinus thrombosis. On an unspecified date she was pronounced brain dead and subsequently died the same day. It was unspecified if an autopsy was performed. Information is limited in this case, but the CVST could represent background incidence of such event in general population, however a relationship with Janssen Covid-19 vaccine cannot be ruled out.  Therefore, the relationship is indeterminant. Additional information has been requested.; Reported Cause(s) of Death: CEREBRAL VENOUS SINUS THROMBOSIS
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test, Sinus disorder, White blood cell count
Clinical narrative: CEREBRAL VENOUS SINUS THROMBOSIS; SEVERE HEADACHE; DIZZINESS; VOMITING; This spontaneous report received from a consumer's sister via (1198162-1) concerned a 45-year-old female. The patient's weight, height, and medical history were not reported.  The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered once on 13-MAR-2021 as prophylactic vaccination. No concomitant medications were reported.  On 20-MAR-2021, (one-week post-vaccination), the patient experienced severe headache, dizziness, and vomiting. The patient visited an emergency room (ER) as the symptoms continued.  On an unspecified date, in the ER, the patient experienced cerebral venous sinus thrombosis. She was pronounced brain death, and the same day she was pronounced dead. It was unspecified if an autopsy was performed.  The action taken with COVID-19 vaccine ad26.cov2.s was not applicable. The patient died of cerebral venous sinus thrombosis, and had not recovered from dizziness, vomiting, and severe headache. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0: This case concerns a 45-year-old female patient who experienced a fatal cerebral venous sinus thrombosis (CVST) 7 days after receiving covid-19 vaccine ad26.cov2.s for prevention of symptomatic SARS-CoV-2 virus infection. The patient experienced severe headache, dizziness, and vomiting 7 days after vaccination which prompted a visit to the emergency department where she was diagnosed with the cerebral venous sinus thrombosis. On an unspecified date she was pronounced brain dead and subsequently died the same day. It was unspecified if an autopsy was performed. Information is limited in this case, but the CVST could represent background incidence of such event in general population, however a relationship with Janssen Covid-19 vaccine cannot be ruled out.  Therefore, the relationship is indeterminant. Additional information has been requested.; Reported Cause(s) of Death: CEREBRAL VENOUS SINUS THROMBOSIS
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Photophobia
Clinical narrative: 5 hours after vaccination had chills. they went away in 24 hours but since then for 16 days has been lightheadheaded, had a headache and now has facial numbness
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Headache, Hypoaesthesia, Laboratory test
Clinical narrative: 5 hours after vaccination had chills. they went away in 24 hours but since then for 16 days has been lightheadheaded, had a headache and now has facial numbness
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neurological examination
Clinical narrative: 5 hours after vaccination had chills. they went away in 24 hours but since then for 16 days has been lightheadheaded, had a headache and now has facial numbness
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiocardiogram, Angiogram pulmonary, Chest X-ray, Chest discomfort, Discomfort
Clinical narrative: Started 4/3/21 SOB Tightness in chest Charlie Horse feeling in RT calf went to urgent care then ER DX: PE/DVT on 4/7/2021
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram, Feeling abnormal, Headache, Limb discomfort
Clinical narrative: Started 4/3/21 SOB Tightness in chest Charlie Horse feeling in RT calf went to urgent care then ER DX: PE/DVT on 4/7/2021
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle spasms, Ultrasound Doppler
Clinical narrative: Started 4/3/21 SOB Tightness in chest Charlie Horse feeling in RT calf went to urgent care then ER DX: PE/DVT on 4/7/2021
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Chest X-ray, Chest discomfort, Deep vein thrombosis, Dyspnoea
Clinical narrative: Started 4/3/21 SOB Tightness in chest Charlie Horse feeling in RT calf went to urgent care then ER DX: PE/DVT on 4/7/2021
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Laboratory test, Muscle spasms, Pulmonary embolism, Ultrasound scan
Clinical narrative: Started 4/3/21 SOB Tightness in chest Charlie Horse feeling in RT calf went to urgent care then ER DX: PE/DVT on 4/7/2021
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Arthralgia, Chills, Cough, Diarrhoea
Clinical narrative: TASTE METALLIC; DRY COUGH; SORE THROAT; LIGHTHEADED; NUMBNESS OF FINGERS  ARMS LEGS AND LIPS; BODY ACHE; TINGLING OF FINGERS  ARMS LEGS AND LIPS; FEELING COLD; FEVER; FINGERNAILS BEDS TURN PURPLE; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included hashimoto's disease, and concurrent conditions included allergy to sun, aloevera, latex, and bees. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced fingernails beds turn purple. On 08-APR-2021, the subject experienced body ache. On 08-APR-2021, the subject experienced tingling of fingers arms legs and lips. On 08-APR-2021, the subject experienced feeling cold. On 08-APR-2021, the subject experienced lightheaded. On 08-APR-2021, the subject experienced numbness of fingers arms legs and lips. On 08-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 103-104 F. On 12-APR-2021, the subject experienced dry cough. On 12-APR-2021, the subject experienced sore throat. On 13-APR-2021, the subject experienced taste metallic. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lightheaded on 09-APR-2021, and fever on 10-APR-2021, had not recovered from body ache, tingling of fingers arms legs and lips, feeling cold, taste metallic, dry cough, sore throat, and numbness of fingers arms legs and lips, and the outcome of fingernails beds turn purple was not reported. This report was non-serious.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dysgeusia, Feeling abnormal, Feeling cold, Hypoaesthesia
Clinical narrative: TASTE METALLIC; DRY COUGH; SORE THROAT; LIGHTHEADED; NUMBNESS OF FINGERS  ARMS LEGS AND LIPS; BODY ACHE; TINGLING OF FINGERS  ARMS LEGS AND LIPS; FEELING COLD; FEVER; FINGERNAILS BEDS TURN PURPLE; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included hashimoto's disease, and concurrent conditions included allergy to sun, aloevera, latex, and bees. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced fingernails beds turn purple. On 08-APR-2021, the subject experienced body ache. On 08-APR-2021, the subject experienced tingling of fingers arms legs and lips. On 08-APR-2021, the subject experienced feeling cold. On 08-APR-2021, the subject experienced lightheaded. On 08-APR-2021, the subject experienced numbness of fingers arms legs and lips. On 08-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 103-104 F. On 12-APR-2021, the subject experienced dry cough. On 12-APR-2021, the subject experienced sore throat. On 13-APR-2021, the subject experienced taste metallic. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lightheaded on 09-APR-2021, and fever on 10-APR-2021, had not recovered from body ache, tingling of fingers arms legs and lips, feeling cold, taste metallic, dry cough, sore throat, and numbness of fingers arms legs and lips, and the outcome of fingernails beds turn purple was not reported. This report was non-serious.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle spasms, Musculoskeletal stiffness, Oropharyngeal pain, Pain in extremity, Paraesthesia
Clinical narrative: TASTE METALLIC; DRY COUGH; SORE THROAT; LIGHTHEADED; NUMBNESS OF FINGERS  ARMS LEGS AND LIPS; BODY ACHE; TINGLING OF FINGERS  ARMS LEGS AND LIPS; FEELING COLD; FEVER; FINGERNAILS BEDS TURN PURPLE; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included hashimoto's disease, and concurrent conditions included allergy to sun, aloevera, latex, and bees. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced fingernails beds turn purple. On 08-APR-2021, the subject experienced body ache. On 08-APR-2021, the subject experienced tingling of fingers arms legs and lips. On 08-APR-2021, the subject experienced feeling cold. On 08-APR-2021, the subject experienced lightheaded. On 08-APR-2021, the subject experienced numbness of fingers arms legs and lips. On 08-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 103-104 F. On 12-APR-2021, the subject experienced dry cough. On 12-APR-2021, the subject experienced sore throat. On 13-APR-2021, the subject experienced taste metallic. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lightheaded on 09-APR-2021, and fever on 10-APR-2021, had not recovered from body ache, tingling of fingers arms legs and lips, feeling cold, taste metallic, dry cough, sore throat, and numbness of fingers arms legs and lips, and the outcome of fingernails beds turn purple was not reported. This report was non-serious.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia oral, Pyrexia, Respiratory rate increased, Sneezing, Throat irritation
Clinical narrative: TASTE METALLIC; DRY COUGH; SORE THROAT; LIGHTHEADED; NUMBNESS OF FINGERS  ARMS LEGS AND LIPS; BODY ACHE; TINGLING OF FINGERS  ARMS LEGS AND LIPS; FEELING COLD; FEVER; FINGERNAILS BEDS TURN PURPLE; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included hashimoto's disease, and concurrent conditions included allergy to sun, aloevera, latex, and bees. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced fingernails beds turn purple. On 08-APR-2021, the subject experienced body ache. On 08-APR-2021, the subject experienced tingling of fingers arms legs and lips. On 08-APR-2021, the subject experienced feeling cold. On 08-APR-2021, the subject experienced lightheaded. On 08-APR-2021, the subject experienced numbness of fingers arms legs and lips. On 08-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 103-104 F. On 12-APR-2021, the subject experienced dry cough. On 12-APR-2021, the subject experienced sore throat. On 13-APR-2021, the subject experienced taste metallic. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lightheaded on 09-APR-2021, and fever on 10-APR-2021, had not recovered from body ache, tingling of fingers arms legs and lips, feeling cold, taste metallic, dry cough, sore throat, and numbness of fingers arms legs and lips, and the outcome of fingernails beds turn purple was not reported. This report was non-serious.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Cough, Dizziness, Dysgeusia, Feeling cold
Clinical narrative: TASTE METALLIC; DRY COUGH; SORE THROAT; LIGHTHEADED; NUMBNESS OF FINGERS  ARMS LEGS AND LIPS; BODY ACHE; TINGLING OF FINGERS  ARMS LEGS AND LIPS; FEELING COLD; FEVER; FINGERNAILS BEDS TURN PURPLE; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included hashimoto's disease, and concurrent conditions included allergy to sun, aloevera, latex, and bees. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced fingernails beds turn purple. On 08-APR-2021, the subject experienced body ache. On 08-APR-2021, the subject experienced tingling of fingers arms legs and lips. On 08-APR-2021, the subject experienced feeling cold. On 08-APR-2021, the subject experienced lightheaded. On 08-APR-2021, the subject experienced numbness of fingers arms legs and lips. On 08-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 103-104 F. On 12-APR-2021, the subject experienced dry cough. On 12-APR-2021, the subject experienced sore throat. On 13-APR-2021, the subject experienced taste metallic. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lightheaded on 09-APR-2021, and fever on 10-APR-2021, had not recovered from body ache, tingling of fingers arms legs and lips, feeling cold, taste metallic, dry cough, sore throat, and numbness of fingers arms legs and lips, and the outcome of fingernails beds turn purple was not reported. This report was non-serious.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Nail discolouration, Oropharyngeal pain, Pain, Paraesthesia
Clinical narrative: TASTE METALLIC; DRY COUGH; SORE THROAT; LIGHTHEADED; NUMBNESS OF FINGERS  ARMS LEGS AND LIPS; BODY ACHE; TINGLING OF FINGERS  ARMS LEGS AND LIPS; FEELING COLD; FEVER; FINGERNAILS BEDS TURN PURPLE; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included hashimoto's disease, and concurrent conditions included allergy to sun, aloevera, latex, and bees. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced fingernails beds turn purple. On 08-APR-2021, the subject experienced body ache. On 08-APR-2021, the subject experienced tingling of fingers arms legs and lips. On 08-APR-2021, the subject experienced feeling cold. On 08-APR-2021, the subject experienced lightheaded. On 08-APR-2021, the subject experienced numbness of fingers arms legs and lips. On 08-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 103-104 F. On 12-APR-2021, the subject experienced dry cough. On 12-APR-2021, the subject experienced sore throat. On 13-APR-2021, the subject experienced taste metallic. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lightheaded on 09-APR-2021, and fever on 10-APR-2021, had not recovered from body ache, tingling of fingers arms legs and lips, feeling cold, taste metallic, dry cough, sore throat, and numbness of fingers arms legs and lips, and the outcome of fingernails beds turn purple was not reported. This report was non-serious.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: TASTE METALLIC; DRY COUGH; SORE THROAT; LIGHTHEADED; NUMBNESS OF FINGERS  ARMS LEGS AND LIPS; BODY ACHE; TINGLING OF FINGERS  ARMS LEGS AND LIPS; FEELING COLD; FEVER; FINGERNAILS BEDS TURN PURPLE; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included hashimoto's disease, and concurrent conditions included allergy to sun, aloevera, latex, and bees. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced fingernails beds turn purple. On 08-APR-2021, the subject experienced body ache. On 08-APR-2021, the subject experienced tingling of fingers arms legs and lips. On 08-APR-2021, the subject experienced feeling cold. On 08-APR-2021, the subject experienced lightheaded. On 08-APR-2021, the subject experienced numbness of fingers arms legs and lips. On 08-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 103-104 F. On 12-APR-2021, the subject experienced dry cough. On 12-APR-2021, the subject experienced sore throat. On 13-APR-2021, the subject experienced taste metallic. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lightheaded on 09-APR-2021, and fever on 10-APR-2021, had not recovered from body ache, tingling of fingers arms legs and lips, feeling cold, taste metallic, dry cough, sore throat, and numbness of fingers arms legs and lips, and the outcome of fingernails beds turn purple was not reported. This report was non-serious.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Cough, Dyspnoea, Exposure to toxic agent, Immediate post-injection reaction
Clinical narrative: Nausea, Body Aches, Mid Sternal Chest Pain, Shortness of Breath
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, Myalgia, Nausea
Clinical narrative: Nausea, Body Aches, Mid Sternal Chest Pain, Shortness of Breath
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Nausea, Pain
Clinical narrative: Nausea, Body Aches, Mid Sternal Chest Pain, Shortness of Breath
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Rash, Rash pruritic, Urticaria
Clinical narrative: HEADACHE; INJECTION SITE SKIN  BREAK OUT; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. The patient's past medical history included cannabidiol abuse, and concurrent conditions included psoriasis, ketosis, eczema, non smoker, and alcohol use. The patient experienced drug allergy when treated with lidocaine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 201A21A) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the subject experienced injection site skin break out. On an unspecified date, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from injection site skin break out, and the outcome of headache was not reported. This report was non-serious.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Injection site swelling
Clinical narrative: HEADACHE; INJECTION SITE SKIN  BREAK OUT; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. The patient's past medical history included cannabidiol abuse, and concurrent conditions included psoriasis, ketosis, eczema, non smoker, and alcohol use. The patient experienced drug allergy when treated with lidocaine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 201A21A) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the subject experienced injection site skin break out. On an unspecified date, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from injection site skin break out, and the outcome of headache was not reported. This report was non-serious.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Disorientation, Transient global amnesia, Urine analysis, X-ray
Clinical narrative: Diagnosed TGA - started approximately 5:45 pm on 03/17/2021 after I got home from work.   Started repeatedly asking my husband the same question over and over again as if I was on a loop.  I don't remember anything for the next couple hours.  I was taken to the hospital, where several tests were run and nothing showed why.  Saw my family doctor, on 03/22/2021 and he had reviewed my tests and diagnosed TGA.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amnesia, Magnetic resonance imaging, Repetitive speech
Clinical narrative: Diagnosed TGA - started approximately 5:45 pm on 03/17/2021 after I got home from work.   Started repeatedly asking my husband the same question over and over again as if I was on a loop.  I don't remember anything for the next couple hours.  I was taken to the hospital, where several tests were run and nothing showed why.  Saw my family doctor, on 03/22/2021 and he had reviewed my tests and diagnosed TGA.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient hospitalized within 6 weeks of receiving COVID vaccination.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear congestion, Head discomfort, Headache, Hypoaesthesia, Immediate post-injection reaction
Clinical narrative: DIARRHEA; FEVER; HEADACHE; PAIN IN THE RIGHT ARM /PAIN AT INJECTION SITE/NUMBNESS IN RIGHT ARM; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included cancer survival. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021, the subject experienced diarrhea. On 30-MAR-2021, the subject experienced fever. On 30-MAR-2021, the subject experienced headache. On 30-MAR-2021, the subject experienced pain in the right arm /pain at injection site/numbness in right arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, headache, diarrhea, and pain in the right arm /pain at injection site/numbness in right arm. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Noninfective encephalitis, Paraesthesia, Tinnitus
Clinical narrative: DIARRHEA; FEVER; HEADACHE; PAIN IN THE RIGHT ARM /PAIN AT INJECTION SITE/NUMBNESS IN RIGHT ARM; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included cancer survival. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021, the subject experienced diarrhea. On 30-MAR-2021, the subject experienced fever. On 30-MAR-2021, the subject experienced headache. On 30-MAR-2021, the subject experienced pain in the right arm /pain at injection site/numbness in right arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, headache, diarrhea, and pain in the right arm /pain at injection site/numbness in right arm. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Headache, Injection site reaction, Pyrexia
Clinical narrative: DIARRHEA; FEVER; HEADACHE; PAIN IN THE RIGHT ARM /PAIN AT INJECTION SITE/NUMBNESS IN RIGHT ARM; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included cancer survival. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021, the subject experienced diarrhea. On 30-MAR-2021, the subject experienced fever. On 30-MAR-2021, the subject experienced headache. On 30-MAR-2021, the subject experienced pain in the right arm /pain at injection site/numbness in right arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, headache, diarrhea, and pain in the right arm /pain at injection site/numbness in right arm. This report was non-serious.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Dizziness, Hyperhidrosis, Nervousness, Photophobia
Clinical narrative: PROFUSE SWEATING; SHORTNESS OF BREATH; EYES SENSITIVE TO BRIGHT LIGHT; FEELS AWFUL; PHOTOSENSITIVITY; SICK TO STOMACH/NAUSEA; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: not reported) dose was not reported, administered on 29-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-MAR-2021, the subject experienced profuse sweating. On 29-MAR-2021, the subject experienced shortness of breath. On 29-MAR-2021, the subject experienced eyes sensitive to bright light. On 29-MAR-2021, the subject experienced feels awful. On 29-MAR-2021, the subject experienced photosensitivity. On 29-MAR-2021, the subject experienced sick to stomach/nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from profuse sweating, shortness of breath, eyes sensitive to bright light, feels awful, photosensitivity, and sick to stomach/nausea on 29-MAR-2021. This report was non-serious.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Feeling abnormal, Hyperhidrosis, Nausea, Photophobia
Clinical narrative: PROFUSE SWEATING; SHORTNESS OF BREATH; EYES SENSITIVE TO BRIGHT LIGHT; FEELS AWFUL; PHOTOSENSITIVITY; SICK TO STOMACH/NAUSEA; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: not reported) dose was not reported, administered on 29-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-MAR-2021, the subject experienced profuse sweating. On 29-MAR-2021, the subject experienced shortness of breath. On 29-MAR-2021, the subject experienced eyes sensitive to bright light. On 29-MAR-2021, the subject experienced feels awful. On 29-MAR-2021, the subject experienced photosensitivity. On 29-MAR-2021, the subject experienced sick to stomach/nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from profuse sweating, shortness of breath, eyes sensitive to bright light, feels awful, photosensitivity, and sick to stomach/nausea on 29-MAR-2021. This report was non-serious.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Photosensitivity reaction
Clinical narrative: PROFUSE SWEATING; SHORTNESS OF BREATH; EYES SENSITIVE TO BRIGHT LIGHT; FEELS AWFUL; PHOTOSENSITIVITY; SICK TO STOMACH/NAUSEA; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: not reported) dose was not reported, administered on 29-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-MAR-2021, the subject experienced profuse sweating. On 29-MAR-2021, the subject experienced shortness of breath. On 29-MAR-2021, the subject experienced eyes sensitive to bright light. On 29-MAR-2021, the subject experienced feels awful. On 29-MAR-2021, the subject experienced photosensitivity. On 29-MAR-2021, the subject experienced sick to stomach/nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from profuse sweating, shortness of breath, eyes sensitive to bright light, feels awful, photosensitivity, and sick to stomach/nausea on 29-MAR-2021. This report was non-serious.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Computerised tomogram, Electrocardiogram, Laboratory test, Tachycardia
Clinical narrative: Approximately 6 hours after being vaccinated, the patient's heart rate skyrocketed to 178 bpm, as measured by an Apple watch.  In the next few minutes it settle to about 120 bpm.  On the way to the ER it skyrocketed again to 150 bpm, then settled to about 115 bpm.    Over the next 6 hours it slowly decreased to about 100 bpm and did not return to normal until 24 hours after the initial vaccination shot.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Heart rate increased, Scan
Clinical narrative: Approximately 6 hours after being vaccinated, the patient's heart rate skyrocketed to 178 bpm, as measured by an Apple watch.  In the next few minutes it settle to about 120 bpm.  On the way to the ER it skyrocketed again to 150 bpm, then settled to about 115 bpm.    Over the next 6 hours it slowly decreased to about 100 bpm and did not return to normal until 24 hours after the initial vaccination shot.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Autoimmune disorder, Burning sensation, Chest pain, Chills, Electrocardiogram
Clinical narrative: STABBING CHEST PAIN; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 49 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included echocardiogram normal, cardiac stress test normal.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 20-MAR-2021 16:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAR-2021, the subject experienced stabbing chest pain. On MAR-2021, the subject experienced flu like symptoms. Laboratory data (dates unspecified) included: EKG (NR: not provided) Normal, Heart rate (NR: not provided) Normal, and Oxygen saturation (NR: not provided) Normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms on MAR-2021, and had not recovered from stabbing chest pain. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer increased, Inflammation, Influenza like illness, Limb discomfort, Pain
Clinical narrative: STABBING CHEST PAIN; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 49 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included echocardiogram normal, cardiac stress test normal.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 20-MAR-2021 16:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAR-2021, the subject experienced stabbing chest pain. On MAR-2021, the subject experienced flu like symptoms. Laboratory data (dates unspecified) included: EKG (NR: not provided) Normal, Heart rate (NR: not provided) Normal, and Oxygen saturation (NR: not provided) Normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms on MAR-2021, and had not recovered from stabbing chest pain. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.